Effects of selegiline pretreatment on
response to experimental cocaine administration

Newton TF, Kalechstein A, Beckson M,
Bartzokis G, Bridge TP, Ling W
Department of Psychiatry and Biobehavioral Sciences,
UCLA, School of Medicine,
Los Angeles, CA 90073, USA.
Psychiatry Res 1999 Oct 11; 87(2-3):101-6


Several medications have been reported to alter the subjective effects of experimentally administered cocaine. We studied the effects of selegiline, a monoamine oxidase B inhibitor, on the subjective effects of experimentally administered cocaine in chronically cocaine-dependent subjects. Eight subjects completed a protocol that involved repeated administrations of cocaine before and after treatment with selegiline, given in extended release form, 10 mg per day. Four days of treatment with selegiline was associated with decreased self-reported 'high' and 'stimulated' feelings after cocaine administration, measured as the area under the curve. Changes in other subjective effects were less pronounced. Selegiline pretreatment had minimal effects on the cardiovascular responses to cocaine administration.
The cheese effect
Parkinson's disease
Alzheimer's disease
Selegiline and cocaine
Selegiline and the brain
Selegiline and nitric oxide
Selegiline for longer-lived flies
Selegiline and life-expectancy
Selegiline as an immunostimulant
MAOIs and cocaine discrimination
Selegiline, cocaine and dopamine function

and further reading

Future Opioids
BLTC Research
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family